ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 729529 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 729529; 2) Community: the network communities that were significantly associated with the response to NSC 729529; 3) Molecule: the relationships between components within communities and NSC 729529; 4) MDR: the compounds that were significantly associated with the NSC 729529.

NSC Compound Enrichment Correlation
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0348927754043159 0.56504726
NSC 267713 Digitoxigenin glycoside 0.0348927754043159 0.22565663
NSC 300289 Pinafide 0.0348927754043159 0.2920498
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0348927754043159 0.42031319
NSC 30915 Null 0.0348927754043159 0.15856694
NSC 328410 Camptothecin Derivative 0.0348927754043159 0.31844328
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.0348927754043159 0.28992954
NSC 33570 Null 0.0348927754043159 0.50258293
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0348927754043159 0.55322438
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0348927754043159 0.42412719
Total:107  Current:72    [First] [Prev] [Next] [Last]